Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
chiara.lanzillotta@uniroma1.it
Chiara Lanzillotta
Assegnista di ricerca
Struttura:
DIPARTIMENTO DI SCIENZE BIOCHIMICHE "ALESSANDRO ROSSI FANELLI"
E-mail:
chiara.lanzillotta@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Redox imbalance and metabolic defects in the context of Alzheimer disease
FEBS LETTERS
2024
Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model
NEUROBIOLOGY OF DISEASE
2024
Biliverdin reductase-A integrates insulin signaling with mitochondrial metabolism through phosphorylation of GSK3β
REDOX BIOLOGY
2024
Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome
NEUROPHARMACOLOGY
2023
Dynamic Changes of BVRA Protein Levels Occur in Response to Insulin: A Pilot Study in Humans
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
The disturbance of protein synthesis/degradation homeostasis is a common trait of age-related neurodegenerative disorders
ADVANCES IN PROTEIN CHEMISTRY AND STRUCTURAL BIOLOGY
2022
Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: a harmful synergistic path in down syndrome
FREE RADICAL BIOLOGY & MEDICINE
2021
Stress responses in down syndrome neurodegeneration: State of the art and therapeutic molecules
BIOMOLECULES
2021
High-fat diet leads to reduced protein o-glcnacylation and mitochondrial defects promoting the development of alzheimer’s disease signatures
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021
Broad kinase inhibition mitigates early neuronal dysfunction in tauopathy
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021
Protein oxidative damage in UV-related skin cancer and dysplastic lesions contributes to neoplastic promotion and progression
CANCERS
2020
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
NEUROBIOLOGY OF DISEASE
2020
The GALA project. practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian experts
ORPHANET JOURNAL OF RARE DISEASES
2020
Chronic perk induction promotes alzheimer-like neuropathology in down syndrome: Insights for therapeutic intervention
PROGRESS IN NEUROBIOLOGY
2020
Cytosolic serine hydroxymethyltransferase controls lung adenocarcinoma cells migratory ability by modulating AMP kinase activity
CELL DEATH & DISEASE
2020
The dysregulation of OGT/OGA cycle mediates Tau and APP neuropathology in down syndrome
NEUROTHERAPEUTICS
2020
Proteomics study of peripheral blood mononuclear cells in down syndrome children
ANTIOXIDANTS
2020
BVR-A deficiency leads to autophagy impairment through the dysregulation of AMPK/mTOR axis in the brain—Implications for neurodegeneration
ANTIOXIDANTS
2020
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease
NEUROBIOLOGY OF DISEASE
2019
Reduced biliverdin reductase-a levels are associated with early alterations of insulin signaling in obesity
BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE
2019
1
2
seguente ›
ultima »
Progetti di Ricerca
The pharmacological increase of protein O-GlcNAcylation rescue Down syndrome neuropathology: a proteomics analysis of molecular targets
Role of PERK in the regulation of Nrf2 related antioxidant response in Down syndrome neuropathology
The link between aberrant brain metabolism and cognitive decline in Down syndrome neuropathology: A novel role for altered protein O-GlcNAcylation
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma